Thryve
Thryve is a digital health company that transforms wearable health data into actionable insights to empower healthcare providers, insurers, and researchers with personalized, preventive care solutions.
Classification
Profile
Funding
Funding details not yet available.
Compliance
Fundraising & market
Transforms wearable health data into actionable insights for personalized, preventive care, aiming to help people live 20 more healthy years.
Insurers, healthcare providers, and researchers globally who need secure, compliant health analytics.
SaaS API licensing with usage-based pricing for data analytics and platform access.
Direct sales via webinars and demo bookings; B2B focus rather than PLG.
Wearable device manufacturers and healthcare ecosystems enabling data integration.
R&D for API and analytics platform, compliance/security infrastructure, and sales/marketing.
Proprietary Wearable Healthcare API, analytics engine, and compliance-certified data processing capabilities.
Developing API/analytics tools, ensuring data security/compliance, and empowering clients with preventive care solutions.
Sales-led enterprise relationships supported by educational content like webinars.
Competes in digital health analytics; differentiates through full data security, compliance, and focus on preventive care impact.
Insurers/providers lack actionable, personalized preventive care data; need secure, compliant ways to leverage wearable health metrics.
- Introduce an AI-Driven Insights Marketplace - Package predictive risk scores (e.g., cardiovascular event likelihood) as add-on modules. T
Are you focusing the analysis on Thryve Health (the API platform) only, or do you also want to incorporate the Thryve Care membership practi · What is the current pricing structure (flat-rate vs. usage-based) and customer churn rate? · Do you have any strategic goals (e.g., entering the US market, launching analytics SaaS) that should be reflected
- Regulatory Certifications - Thryve holds GDPR, HIPAA, ISO 27001/9001 certifications and hosts data in Germany, a rare combination that bu
No investors recorded yet.